Global Flea and Tick Products Market to Reach $11.2 Billion by 2030
The global market for Flea and Tick Products estimated at US$6.1 Billion in the year 2022, is projected to reach a revised size of US$11.2 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2022-2030. Chewable, one of the segments analyzed in the report, is projected to record 7.5% CAGR and reach US$7.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Spot On segment is readjusted to a revised 8.6% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 12.8% CAGR
The Flea and Tick Products market in the U.S. is estimated at US$1.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 7.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.Select Competitors (Total 46 Featured) -
- Bayer AG
- Central Life Sciences
- Ceva Sante Animale
- Ecto Development Corporation
- Eli Lilly and Company
- Merck Animal Health
- Sergeant's Pet Care Products, Inc.
- The Hartz Mountain Corporation
- Virbac Group
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Central Life Sciences
- Ceva Sante Animale
- Ecto Development Corporation
- Eli Lilly and Company
- Merck Animal Health
- Sergeant's Pet Care Products, Inc.
- The Hartz Mountain Corporation
- Virbac Group
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 196 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 6.1 Billion |
Forecasted Market Value ( USD | $ 11.2 Billion |
Compound Annual Growth Rate | 7.9% |
Regions Covered | Global |